GlassScriptPhysician profile
Emily Niles
NPI 1023502234
$1,723.74
in general payments reported to CMS, 2019-2025
26 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $64.93 · 2021: $62.31 · 2022: $198 · 2023: $199 · 2024: $117 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986 · Travel and Lodging: $54.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.59 |
| Travel and Lodging | $54.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $220.91 | 2020-2025 | 7 X 23mm Citrelock Implant, Prostep Mica |
| Musculoskeletal Transplant Foundation INC. | $180.70 | 2019-2023 | |
| Abbvie INC. | $156.35 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $149.78 | 2024-2025 | Nuzyra |
| Horizon Therapeutics Plc | $147.32 | 2019-2022 | |
| Treace Medical Concepts, INC. | $113.51 | 2023-2025 | |
| Acera Surgical, INC. | $102.60 | 2022-2023 | Restrata Wound Matrix |
| Organogenesis INC. | $87.15 | 2025 | Via Matrix, Puraply Wound Matrix, Novachor |
| Smith+Nephew, INC. | $78.77 | 2021-2025 | Grafix Pl, Oasis, Collagenase Santyl |
| Medtronic, INC. | $73.05 | 2022-2025 | Inceptiv |
| Amgen INC. | $69.01 | 2025 | Krystexxa |
| Curonix LLC | $34.07 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $32.29 | 2025 | Senza |
| Access Pro Medical, LLC | $31.81 | 2023 | Matriderm |
| Zyla Life Sciences, INC. | $29.93 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $26.57 | 2024 | Miro3d |
| Averitas Pharma INC. | $25.62 | 2025 | Qutenza |
| Biocomposites INC | $24.52 | 2019 | |
| Convatec INC. | $22.00 | 2024 | |
| Mimedx Group, INC. | $21.14 | 2024 | |
| Stimwave Technologies Incorporated | $20.64 | 2021 | |
| Melinta Therapeutics, LLC | $20.56 | 2021 | |
| Avita Medical Americas, LLC | $16.12 | 2025 | Cohealyx, Permeaderm, Recell |
| Innovation Technologies INC | $15.82 | 2025 | Irrisept |
| Acell, INC. | $13.24 | 2019 | |
| Orthofix Medical, INC. | $10.26 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Niles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.